Eduardo Sobarzo-Sánchez

Prof. Eduardo Sobarzo-Sánchez

Centro de Investigación en Ingeniería de Materiales-CIIMAT, Facultad de Medicina y Ciencias de la Salud, Universidad Central de Chile, Santiago, Región Metropolitana, Chile
orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2020 in Cancers
Verified
Journal Article
Open access
PDF file
Esra KÜPELİEsra KÜPELİ
Esra KÜPELİ
YGYasin Genç
Yasin Genç
BKBüşra Karpuz
Büşra Karpuz
Eduardo Sobarzo-SánchezEduardo Sobarzo-Sánchez
Eduardo Sobarzo-Sánchez
Raffaele CapassoRaffaele Capasso
Raffaele Capasso
Cancer is one of the most common causes of disease-related deaths worldwide. Despite the discovery of many chemotherapeutic drugs that inhibit uncontrolled cell division processes for the treatment of various cancers, serious side effects of these drugs are a crucial disadvantage. In addition, multi-drug resistance is another important problem in anticancer treatment. Due to problems such as cytotoxicity and drug resistance, many investigations are being conducted to discover and develop effective anticancer drugs. In recent years, researchers have focused on the anticancer activity coumarins, due to their high biological activity and low toxicity. Coumarins are commonly used in the treatment of prostate cancer, renal cell carcinoma and leukemia, and they also have the ability to counteract the side effects caused by radiotherapy. Both natural and synthetic coumarin derivatives draw attention due to their photochemotherapy and therapeutic applications in cancer. In this review, a compilation of various research reports on coumarins with anticancer activity and investigation and a review of structure-activity relationship studies on coumarin core are presented. Determination of important structural features around the coumarin core may help researchers to design and develop new analogues with a strong anticancer effect and reduce the potential side effects of existing therapeutics.

1 October 2015 in Brain Research Bulletin
Verified
Journal Article
Closed access
SNSeyed Fazel Nabavi
Seyed Fazel Nabavi
Nady BraidyNady Braidy
Nady Braidy
OGOlga Gortzi
Olga Gortzi
Eduardo Sobarzo-SánchezEduardo Sobarzo-Sánchez
Eduardo Sobarzo-Sánchez
MDMaria Daglia
Maria Daglia
Seyed Mohammad NabaviSeyed Mohammad Nabavi
Seyed Mohammad Nabavi

12 February 2019 in Molecules
Verified
Journal Article
Open access
PDF file
MHMarziyeh Hajialyani
Marziyeh Hajialyani
MFMohammad Hosein Farzaei
Mohammad Hosein Farzaei
Javier EcheverríaJavier Echeverría
Javier Echeverría
Seyed Mohammad NabaviSeyed Mohammad Nabavi
Seyed Mohammad Nabavi
EUEugenio Uriarte
Eugenio Uriarte
Eduardo Sobarzo-SánchezEduardo Sobarzo-Sánchez
Eduardo Sobarzo-Sánchez
Neuroprotection is the preservation of function and networks of neural tissues from damages caused by various agents, as well as neurodegenerative diseases such as Parkinson’s, Alzheimer’s, Huntington’s diseases, and multiple sclerosis. Hesperidin, a flavanone glycoside, is a natural phenolic compound with a wide range of biological effects. Mounting evidence has demonstrated that hesperidin possesses inhibitory effect against development of neurodegenerative diseases. Our review discusses neuropharmacological mechanisms for preventive and therapeutic effects of hesperidin in neurodegenerative diseases. In addition, the review examines clinical evidence confirming its neuroprotective function. Various cellular and animal models specific to neurodegenerative diseases have been conducted to evaluate the underlying neuropharmacological mechanisms of hesperidin. Neuroprotective potential of this flavonoid is mediated by improvement of neural growth factors and endogenous antioxidant defense functions, diminishing neuro-inflammatory and apoptotic pathways. Despite the various preclinical studies on the role of hesperidin in the neurodegenerative diseases, less is known about its definite effect on humans. A limited number of clinical trials showed that hesperidin-enriched dietary supplements can significantly improve cerebral blood flow, cognition, and memory performance. Further clinical trials are also required for confirming neuroprotective efficacy of this natural flavonoid and evaluating its safety profile.

11 September 2015 in Nutrients
Verified
Journal Article
Open access
PDF file
SNSeyed Fazel Nabavi
Seyed Fazel Nabavi
ALArianna Di Lorenzo
Arianna Di Lorenzo
MIMorteza Izadi
Morteza Izadi
Eduardo Sobarzo-SánchezEduardo Sobarzo-Sánchez
Eduardo Sobarzo-Sánchez
MDMaria Daglia
Maria Daglia
Seyed Mohammad NabaviSeyed Mohammad Nabavi
Seyed Mohammad Nabavi
Herbs and spices have been used since ancient times, because of their antimicrobial properties increasing the safety and shelf life of food products by acting against foodborne pathogens and spoilage bacteria. Plants have historically been used in traditional medicine as sources of natural antimicrobial substances for the treatment of infectious disease. Therefore, much attention has been paid to medicinal plants as a source of alternative antimicrobial strategies. Moreover, due to the growing demand for preservative-free cosmetics, herbal extracts with antimicrobial activity have recently been used in the cosmetic industry to reduce the risk of allergies connected to the presence of methylparabens. Some species belonging to the genus Cinnamomum, commonly used as spices, contain many antibacterial compounds. This paper reviews the literature published over the last five years regarding the antibacterial effects of cinnamon. In addition, a brief summary of the history, traditional uses, phytochemical constituents, and clinical impact of cinnamon is provided.

21 August 2015 in Current Topics in Medicinal Chemistry
Verified
Journal Article
Closed access
Seyed Mohammad NabaviSeyed Mohammad Nabavi
Seyed Mohammad Nabavi
RTRaman Thiagarajan
Raman Thiagarajan
Luca RastrelliLuca Rastrelli
Luca Rastrelli
MDMaria Daglia
Maria Daglia
Eduardo Sobarzo-SánchezEduardo Sobarzo-Sánchez
Eduardo Sobarzo-Sánchez
HAHeshmatollah Alinezhad
Heshmatollah Alinezhad
Curcumin is the yellow-colored bioactive constituent of the perennial plant, Curcuma longa L., which possesses a wide range of physiological and pharmacological properties such as antioxidant, anti-inflammatory, anticancer, neuroprotective and anti-diabetic activities. Anti-diabetic activity of curcumin may be due to its potent ability to suppress oxidative stress and inflammation. Moreover, it shows a beneficial role on the diabetesinduced endothelial dysfunction and induces a down-regulation of nuclear factor-kappa B. Curcumin possesses a protective role against advanced glycation as well as collagen crosslinking and through this way, mitigates advanced glycation end products-induced complications of diabetes. Curcumin also reduces blood glucose, and the levels of glycosylated hemoglobin in diabetic rat through the regulation of polyol pathway. It also suppresses increased bone resorption through the inhibition of osteoclastogenesis and expression of the AP-1 transcription factors, c-fos and c-jun, in diabetic animals. Overall, scientific literature shows that curcumin possesses anti-diabetic effects and mitigates diabetes complications. Here we report a systematical discussion on the beneficial role of curcumin on diabetes and its complications with emphasis on its molecular mechanisms of actions.

20 July 2019 in Molecules
Verified
Journal Article
Open access
PDF file
SFSajad Fakhri
Sajad Fakhri
Ina AnevaIna Aneva
Ina Aneva
MFMohammad Hosein Farzaei
Mohammad Hosein Farzaei
Eduardo Sobarzo-SánchezEduardo Sobarzo-Sánchez
Eduardo Sobarzo-Sánchez
As the leading causes of human disability and mortality, neurological diseases affect millions of people worldwide and are on the rise. Although the general roles of several signaling pathways in the pathogenesis of neurodegenerative disorders have so far been identified, the exact pathophysiology of neuronal disorders and their effective treatments have not yet been precisely elucidated. This requires multi-target treatments, which should simultaneously attenuate neuronal inflammation, oxidative stress, and apoptosis. In this regard, astaxanthin (AST) has gained growing interest as a multi-target pharmacological agent against neurological disorders including Parkinson’s disease (PD), Alzheimer’s disease (AD), brain and spinal cord injuries, neuropathic pain (NP), aging, depression, and autism. The present review highlights the neuroprotective effects of AST mainly based on its anti-inflammatory, antioxidative, and anti-apoptotic properties that underlies its pharmacological mechanisms of action to tackle neurodegeneration. The need to develop novel AST delivery systems, including nanoformulations, targeted therapy, and beyond, is also considered.